Results from a clinical trial show that giving people with high blood pressure an injection every six months can lead to a meaningful, sustained reduction in their blood pressure. Results from a ...
The injection is given under the skin. The next steps for zilebesiran involve another Phase 2 study, KARDIA-3, to see whether this treatment has the potential to be used to treat people with high ...
The injection is given under the skin. The next steps for zilebesiran involve another Phase 2 study, KARDIA-3, to see if this treatment has potential to be used to treat people with high blood ...
The injection is given under the skin. The next steps for zilebesiran involve another Phase 2 study, KARDIA-3, to see if this treatment has potential to be used to treat people with high blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results